Bio/Pharma News

Merck Signs Cancer Deal with Spanish National Cancer Research Centre

December 19, 2013

Merck Serono, the biopharmaceutical division of Merck, has entered into an agreement on cancer drug development with the Spanish National Cancer Research Centre (CNIO) in Madrid.

Merck KGaA Expands German Production Facility for Allergopharma Unit

December 17, 2013

Merck's new facility for aseptic production in Reinbek, Germany is scheduled to be completed in 2016.

MedImmune Collaborates with Johns Hopkins University

December 17, 2013

AstraZeneca's MedImmune will collaborate with Johns Hopkins University in both biologics and small-molecule projects.

Moberg Pharma Acquires OTC Brands from Bayer

December 12, 2013

Moberg Pharma will acquire three OTC brands from Bayer HealthCare.

GSK Launches Cancer Research Consortium

December 12, 2013

GSK forms the Oncology Clinical and Translational Consortium, a scientific research network comprised of six international cancer centers.

J&J Innovation Announces Opening of Offices

December 12, 2013

Johnson&Johnson will open a network of partnering offices across the UK.

AstraZeneca Awarded Damages in Patent-Litigation

December 12, 2013

AstraZeneca will receive $76 million in damages from Apotex Corp., Apotex, and Torpharm.

BMS Names New Board Member

December 12, 2013

Bristol-Myers Squibb has elected Thomas Lynch, Jr., MD to its board of directors.

ScinoPharm Completes China Plant

December 12, 2013

ScinoPharm completes new API manufacturing plant in Changshu, China.

The Impact of Biosimilars on the Innovator Market

December 04, 2013

Jill E. Sackman, D.V.M., PhD, senior consultant at Numerof & Associates, Inc. discusses the market forces impacting biopharmaceutical manufacturing